About 400 reports

  • Increasing Patient Population with Malnutrition & Aging

Globally, about ## in ## deaths is due to cancer.

  • Hospital
  • Nutrition
  • World
  • Market Size
  • Fresenius Group
  • TISSUE CONTACT PROBES MARKET, BY REGION, 2015-2022 (USD MILLION)

Similarly, in March 2013, the University of Maryland sponsored phase II of the ICE-CANCER clinical trial (Spray Cryotherapy for Esophageal Cancer), which aims to evaluate the safety & efficacy profile of CSA Medical, Inc. '

  • Hospital
  • North America
  • United States
  • Forecast
  • Medtronic, Inc.

The lifetime risk of developing colorectal cancer is ## in ##.

  • Hospital
  • North America
  • World
  • Market Size
  • Boston Scientific Corporation

Chapter ## provides an introduction to the report.

  • Cancer
  • Hospital
  • Specialty Hospital
  • United States
  • Demand

These gastroscopes are used to identify objects stuck in the esophagus, esophageal cancer, and Barrett' s syndrome.

  • Hospital
  • World
  • Forecast
  • FUJIFILM Holdings Corporation
  • Olympus Corporation

In the past few years, there has been a rise in morbidity and mortality due to chronic diseases such as esophageal cancer, colon cancer, rectal cancer, and GI related critical disorders.

  • Hospital
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Olympus Corporation
  • Stryker Corporation

DRIVING FACTORS OF GI ENDOSCOPY INCLUDE LIFESTYLE HABITS LIKE TOBACCO SMOKING AND ALCOHOL DRINKING, LOW VEGETABLE INTAKE AND LOW FRUIT INTAKE CAN BE CAUSATIVE TO ESOPHAGEAL CANCER MORTALITY IN CHINA.

  • Hospital
  • World
  • Market Size
  • FUJIFILM Holdings Corporation
  • Olympus Corporation

Also, obesity is on rise world over, which is fast emerging as number one risk factor for many cancer types which includes, breast (after menopause), colon and rectal, esophageal, endometrial, pancreatic, kidney, thyroid and gallbladder.

  • Hospital
  • World
  • Market Size
  • Bracco Imaging S.p.A.
  • GE Healthcare Limited

Technological advancements in endoscopy have led to the development of ultra-MI thoracic procedures, which can be performed on patients with the benign esophageal disease and early-stage esophageal cancer.

  • Hospital
  • Surgery
  • World
  • Forecast
  • Market Size

Also, the patient who has been operated for esophageal cancer requires the nutrition supplements through CVC.

  • Hospital
  • World
  • AngioDynamics, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated

Also, the patients who undergone surgery for esophageal cancer need nutrition supplements through CVC.

  • Hospital
  • World
  • B. Braun Medical
  • Edwards Lifesciences Corporation
  • Teleflex Incorporated

In these areas, lung cancer, gastric cancer and esophageal cancer take up the larger proportion and happen more on male than female, because overall male lung-cancer risks associate with cigarette smoking and Esophageal cancer link to fa

  • Hospital
  • China
  • Demand
  • Supply
  • Novartis AG
  • 6.1.3 BREAST CANCER

Varian will market the Bionix Esophageal APPLICATOR (E-APP) AND THE ANORECTAL APPLICATOR (AR-##) IN NORTH AMERICA.

  • Hospital
  • World
  • Market Size
  • Accuray Incorporated
  • Elekta Group

Metastatic Breast Cancer Pertuzumab& Trastuzumab Phase ## Phase ## Phase ## Company / University Condition Product / Intervention Description Phase Peking University & Cell Biotech Co.

  • Hospital
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

Lung, liver, stomach, colorectal, breast and esophageal cancers are prevalent among the population worldwide.

  • Hospital
  • AngioDynamics, Inc.
  • B. Braun Medical
  • C.R. Bard, Inc.
  • Teleflex Incorporated

Men rank highest for prostate, lung, colorectal, stomach and esophageal cancer rates.

  • Hospital
  • Brazil
  • Alere Inc.
  • Becton Property Group
  • bioMerieux S.A.

C=##& P=IROL-NEWSARTICLE& ID=## CANCER, NSCLC, ESOPHAGEAL CANCER AND GASTRIC CANCERS.

  • Hospital
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • Novartis AG

Further, the treatment for metastatic lung cancer is the commonly treated condition with airway stents which is one of the primary factors behind the market growth.

  • Hospital
  • World
  • Forecast
  • Boston Scientific Corporation
  • Teleflex Incorporated

It is one of the primary treatments used on patients with locally advanced prostate cancer.

  • Hospital
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Jude Medical, Inc.
  • Medtronic, Inc.

Available ##& ey=2021& scsm=##& ssd=##& sort=country& ds=.

  • Hospital
  • Colombia
  • South America
  • Merck & Co., Inc.
  • Pfizer Inc.
  • MARKET SIZE AND FORECAST

Market size and forecast The colonic stents are used to treat one of the most commonly encountered cancers (colorectal cancer) globally.

  • Hospital
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Medtronic, Inc.
  • Taewoong Medical

NY-ESO-## IS A CANCER ANTIGEN EXPRESSED IN A VARIETY OF CANCERS, INCLUDING COLORECTAL, RENAL AND ESOPHAGEAL.

  • Hospital
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

Squamous cell carcinoma however, remains the most common form of esophageal cancer.

  • Cardiology
  • Health Services
  • Hospital
  • World
  • Forecast

However, because the individual' s risk of developing esophageal cancer is low, even in those with reflux disease, the results should not justify reflux treatment solely as a cancer prevention measure.

  • Cancer
  • Hospital
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited
  • FLOTRAC SENSOR HYPOTENSION PREDICTION DEVICE

ESOPHAGEAL CANCER SURGERY BY BIOELECTRICAL IMPEDANCE ANALYSIS (BIA) AND FLOTRAC SYSTEM FLOTRAC SENSOR HYPOTENSION PREDICTION DEVICE - THE EFFECT OF GOAL-DIRECTED FLUID THERAPY ON POSTOPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING LAPAROSCOPIC HEPATOBILIARY OR PANCREATIC SURGERY As

  • Hospital
  • Prosthesis
  • United States
  • Edwards Lifesciences Corporation
  • Valtech Cardio, Ltd.
  • CANCER RESEARCH TECHNOLOGY LTD
  • THE AFFILIATED HOSPITAL OF THE CHINESE ACADEMY OF MILITARY MEDICAL SCIENCES

ESOPHAGEAL CANCER - PIPELINE BY F.

  • Cancer
  • Hospital
  • North America
  • United States
  • Product Initiative
  • MEDIMMUNE ENTERS INTO RESEARCH AGREEMENT WITH CANCER RESEARCH INSTITUTE AND LUDWIG INSTITUTE FOR CANCER RESEARCH

The drug candidate acts by targeting indoleamine ##, ##-dioxygenase-## (IDO-##).

  • Hospital
  • Immunotherapy
  • United States
  • iTeos Therapeutics SA
  • Ludwig Institute For Cancer Research Ltd
  • Clinical Trial profile. 266 Trial Title
  • Target

Esophageal Cancer Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: AUG 2017 LIST OF TABLES LIST OF FIGURES Esophageal Cancer Global Clinical Trials Review, H##, 2017 outlines clinical trials in

  • Clinical Trial
  • Esophageal Cancer
  • Hospital
  • Monoclonal Antibody
  • Product Initiative

One DALY can be interpreted as one lost year of healthy life.

  • Hospital
  • Latin America
  • Mexico
  • North America
  • Market Size

As of 2013, there have been ## sites for upper gastrointestinal cancer (including esophageal cancer, cardiac cancer and gastric cancer), ## sites for colorectal cancer, ## sites for liver cancer, ## sites for nasopharyngeal cancer and ## s

  • Hospital
  • HPV Testing
  • China
  • East Asia
  • OriGene Technologies, Inc.